Concepedia

Author

Brenner De

BASF (United States)

Also Known As

Brenner De, D E Brenner

10

Publications

121

Citations

7

H-Index

16

Concepts

All Affiliations

BASF (United States)
BD

About

Brenner De is an author at BASF (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

81

2

Pharmacology

3

3

81

3

Immunology

2

2

70

4

Pathology

1

1

11

5

Cancer Cell Biology

1

1

11

Brenner De

×

3

Publications

81

Citations

3

H-Index

YearCitations

Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancer.

Creaven Pj, Cowens Jw, Brenner De,

PubMed

1990

46

Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro.

EN Dessypris, Brenner De, Hande Kr

PubMed

1986

24

Dissociation of the verapamil-induced enhancement of doxorubicin's cytotoxicity from changes in cellular accumulation or retention of doxorubicin in pancreatic cancer cell lines.

Chang Bk, Brenner De, Robert Gutman

PubMed

1989

11

Page 1